ICU Medical price to free cash flow ICUI
Market value divided by free cash flow over the last twelve months, since 2010.
- Today, Oct 23, 2026
- 27.3×
- 10-year median
- 39.7×
- Against its 10-year history
- 19th
- percentile: 0 is its lowest day, 100 its highest
- 10-year range
- 22.2× to 369×
- Peer median
- 19.8×
ICU Medical's price to free cash flow is 27.3× as of Oct 23, 2026.
That is below its ten-year median of 39.7×, lower than on 81% of days in the last ten years.
Over that time it ranged from 22.2× in Jan 2025 to 369× in Feb 2020.
The median for 10 medical instruments and supplies stocks of a similar size is 19.8×.
Price to free cash flow over time
The dashed line is the 10-year median and the shaded band the middle half of its days.
Year by year
| Year | End of year | Low | High |
|---|---|---|---|
| 2026 so far | 27.3× | 25.0× | 53.6× |
| 2025 | 50.7× | 22.2× | 53.7× |
| 2024 | 22.3× | 22.3× | 36.6× |
| 2023 | n/m a value too high to mean anything | ||
| 2022 | 275× | 23.5× | 348× |
| 2021 | 26.9× | 22.5× | 43.6× |
| 2020 | 42.2× | 36.5× | 369× |
| 2019 | 319× | 48.2× | 366× |
| 2018 | 47.6× | 35.1× | 170× |
| 2017 | 140× | 35.4× | 143× |
| 2016 | 39.5× | 30.5× | 45.2× |
| 2015 | 39.8× | 23.0× | 42.0× |
| 2014 | 23.8× | 17.7× | 24.5× |
| 2013 | 20.5× | 15.3× | 29.2× |
| 2012 | 16.3× | 13.1× | 21.4× |
| 2011 | 20.0× | 17.7× | 124× |
| 2010 | 107× | 15.1× | 110× |
Against its peers
Companies in Medical - Instruments & Supplies nearest ICU Medical's size, closest first, today.
| Company | Price to free cash flow |
|---|---|
| ICUIICU Medical | 27.3× |
| BMIBadger Meter | 29.2× |
| NVSTEnvista | 15.3× |
| VNTVontier | 12.1× |
| HAEHaemonetics | 18.5× |
| WRBYWarby Parker | 147× |
| MMSIMerit Medical Systems | 27.4× |
| ATRCAtriCure | 56.5× |
| MSAMSA Safety | 19.8× |
| UFPTUFP Technologies | n/m |
| INSPInspire Medical Systems | 17.6× |
| Peer median | 19.8× |
What the price to free cash flow tells you
Market value divided by free cash flow: the cash left after running the business and paying for equipment. Cash is harder to manage than accounting earnings, so many investors trust this more than PE.
Lumpy: a big year of building factories drops cash flow and inflates the ratio without the business getting worse.
More on ICU Medical
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.